We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$947M
AUM Growth
+$67.9M
Cap. Flow
-$19M
Cap. Flow %
-2.01%
Top 10 Hldgs %
31.65%
Holding
277
New
24
Increased
72
Reduced
85
Closed
14

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$16.1M
2
EXC icon
Exelon
EXC
+$6.81M
3
CROX icon
Crocs
CROX
+$5.78M
4
TMO icon
Thermo Fisher Scientific
TMO
+$5.63M
5
AVY icon
Avery Dennison
AVY
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.01%
2 Industrials 17.97%
3 Healthcare 12.8%
4 Consumer Discretionary 12.43%
5 Energy 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLW icon
1
Corning
GLW
$126B
$40.2M 4.24%
2,255,775
+9,495
+0.4% +$156K
GE icon
2
GE Aerospace
GE
$367B
$39.9M 4.21%
296,754
-2,246
-0.8% -$283K
XOM icon
3
ExxonMobil
XOM
$651B
$34.9M 3.69%
344,976
+9,438
+3% +$873K
INTC icon
4
Intel
INTC
$466B
$33.2M 3.51%
1,280,140
+1,830
+0.1% +$44.3K
SON icon
5
Sonoco
SON
$5.76B
$29.1M 3.07%
697,640
-6,720
-1% -$270K
VOD icon
6
Vodafone
VOD
$34.9B
$25.6M 2.71%
639,968
-14,715
-2% -$554K
CSCO icon
7
Cisco
CSCO
$450B
$24.9M 2.63%
1,110,650
+16,060
+1% +$355K
TXN icon
8
Texas Instruments
TXN
$255B
$24.7M 2.6%
561,411
-99,256
-15% -$4.15M
JCI icon
9
Johnson Controls International
JCI
$87.5B
$24.1M 2.54%
448,259
-28,005
-6% -$1.38M
KSS icon
10
Kohl's
KSS
$2.03B
$23.3M 2.46%
409,970
-9,720
-2% -$533K
AVY icon
11
Avery Dennison
AVY
$12.3B
$22.1M 2.33%
440,460
-117,193
-21% -$5.52M
MDT icon
12
Medtronic
MDT
$107B
$20.8M 2.2%
362,528
-3,410
-0.9% -$193K
DD
13
DELISTED
Du Pont De Nemours E I
DD
$19.6M 2.07%
317,870
+3,001
+1% +$173K
AMGN icon
14
Amgen
AMGN
$203B
$16.4M 1.73%
143,992
+1,340
+0.9% +$152K
J icon
15
Jacobs Solutions
J
$15.9B
$16M 1.69%
306,984
+103
+0% +$5.1K
RDUS
16
DELISTED
Radius Recycling
RDUS
$15.5M 1.64%
474,935
+7,670
+2% +$229K
MET icon
17
MetLife
MET
$61B
$14.9M 1.57%
309,335
-7,047
-2% -$316K
JPM icon
18
JPMorgan Chase
JPM
$939B
$14.4M 1.52%
246,479
-2,015
-0.8% -$110K
NWLIA
19
DELISTED
NATL WESTN LIFE INS CO CL A
NWLIA
$14.4M 1.52%
64,447
+505
+0.8% +$113K
ITW icon
20
Illinois Tool Works
ITW
$81.4B
$12.7M 1.34%
150,985
+1,200
+0.8% +$94.7K
UNH icon
21
UnitedHealth
UNH
$382B
$12.5M 1.32%
166,430
+3,700
+2% +$266K
BHI
22
DELISTED
Baker Hughes
BHI
$11.8M 1.25%
214,330
-1,195
-0.6% -$65.5K
MMM icon
23
3M
MMM
$89B
$11.8M 1.25%
100,596
-3,079
-3% -$328K
HCC
24
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
$11.7M 1.24%
254,290
-2,065
-0.8% -$93.1K
COL
25
DELISTED
Rockwell Collins
COL
$10.8M 1.14%
+145,705
New +$10.4M

Similar funds

Shufro Rose & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Shufro Rose & Co held 277 positions worth $947M, up 7.7% from $879M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Shufro Rose & Co's Q4 2013 filing shows 24 new, 72 increased, 85 reduced and 14 closed positions. Its largest new stake was Rockwell Collins: 145,705 shares worth $10.8M. The largest sale was Teva Pharmaceuticals, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.

  • Shufro Rose & Co's largest Q4 2013 buy was Rockwell Collins: 145,705 shares worth $10.8M.
  • Shufro Rose & Co added most to Vishay Precision Group in Q4 2013, an estimated $1.63M increase.
  • Shufro Rose & Co's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $16.1M.
  • Shufro Rose & Co fully exited MAIDENFORM BRANDS, INC in Q4 2013, selling an estimated $4.49M.
  • Shufro Rose & Co's ten largest holdings make up 32% of its $947M portfolio in Q4 2013.
  • Shufro Rose & Co opened 24 new positions and closed 14 in Q4 2013.
  • Shufro Rose & Co's portfolio value rose 7.7% quarter-over-quarter to $947M.

Based on Shufro Rose & Co's 13F filing for Q4 2013, filed 4 Feb 2014.